Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

MPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	611.96	519.86	143.53	83.83	52.6	46.76
Cash & Short-Term Investments	611.96	519.86	143.53	83.83	52.6	46.76
Cash Growth	115.41%	262.20%	71.22%	59.38%	12.48%	-3.01%
Accounts Receivable	410.03	338.14	335.75	78.66	27.92	43.27
Other Receivables	-	-	-	40.02	28.3	16.37
Receivables	410.03	338.14	335.75	208.19	140.35	134.14
Inventory	201.22	254.53	221.22	172.55	160.63	111.24
Prepaid Expenses	-	-	-	1.9	0.49	0.27
Other Current Assets	-0	-	-	14.14	4.35	8.67
Total Current Assets	1,223	1,113	700.49	480.61	358.41	301.08
Property, Plant & Equipment	90.32	86.48	63.5	54.63	44.49	44.17
Long-Term Investments	6.49	6.49	6.49	6.49	6.49	6.49
Other Intangible Assets	7.92	8.83	12.46	16.1	19.73	23.37
Long-Term Deferred Tax Assets	2.99	2.72	2.72	2.47	2.47	2.32
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	1,331	1,217	785.66	560.29	431.58	377.41
Accounts Payable	887.37	694.28	589.12	461.44	401.98	341.21
Accrued Expenses	-	13.89	12.34	10.15	9.34	13.74
Short-Term Debt	33.75	69.27	10.98	4.73	5.36	7.4
Current Unearned Revenue	-	0.09	0.09	0.09	-	0.09
Other Current Liabilities	9.3	178.43	64.27	45.68	50.6	76.07
Total Current Liabilities	930.42	955.97	676.8	522.08	467.28	438.52
Long-Term Debt	109.54	109.54	2.34	-	-	-
Long-Term Deferred Tax Liabilities	2.45	2.45	1.57	1.57	1.37	1.37
Other Long-Term Liabilities	-	-	-	-	1.11	16.39
Total Liabilities	1,042	1,068	680.7	523.65	469.77	456.28
Common Stock	56.25	56.25	56.25	56.25	56.25	56.25
Retained Earnings	221.05	89.34	45.61	-22.7	-97.52	-138.2
Comprehensive Income & Other	11.21	3.49	3.09	3.09	3.09	3.09
Shareholders' Equity	288.51	149.08	104.95	36.64	-38.18	-78.86
Total Liabilities & Equity	1,331	1,217	785.66	560.29	431.58	377.41
Total Debt	143.29	178.82	13.32	4.73	5.36	7.4
Net Cash (Debt)	468.67	341.04	130.21	79.1	47.23	39.36
Net Cash Growth	66.34%	161.92%	64.62%	67.45%	20.02%	-15.55%
Net Cash Per Share	-	60.63	23.15	14.06	-	7.00
Filing Date Shares Outstanding	-	5.63	5.63	5.63	-	5.63
Total Common Shares Outstanding	-	5.63	5.63	5.63	-	5.63
Working Capital	292.79	156.56	23.7	-41.47	-108.87	-137.44
Book Value Per Share	-	26.50	18.66	6.51	-	-14.02
Tangible Book Value	280.59	140.25	92.49	20.55	-57.92	-102.23
Tangible Book Value Per Share	-	24.93	16.44	3.65	-	-18.17
Land	-	0.59	0.59	0.59	0.59	0.59
Buildings	-	93.19	60.56	60.56	59.6	59.36
Machinery	-	148.08	141.61	141.61	140.68	139.51
Construction In Progress	-	20.05	38.51	27.54	16.08	11.43

Source: S&P Capital IQ. Standard template. Financial Sources.